K S Moghissi

No ORCID on file · 12 papers in corpus · active 1975-2000

Study types

  • article 6
  • review 4
  • other 1
  • rct 1

Condition tags

  • mesh:D004715 11
  • endometriosis 9
  • infertility 3
  • adenomyosis 1
review 2000
Medscape women's health

Gonadotropin-releasing hormone (GnRH) and its analogues have been extensively used in clinical medicine since they were identified and synthesized in 1971. Native GnRH stimulates gonadotrophs of the anterior pituitary and has been used for …

review 1999
Clinical obstetrics and gynecology ·doi:10.1097/00003081-199909000-00016

Wayne State University/Hutzel Hospital, Detroit, Michigan Correspondence: Kamran S. Moghissi, MD, Professor, Department of Obstetrics & Gynecology, Division of Reproductive Endocrinology & Infertility, Wayne State University/Hutzel Hospital…

rct 1998
Fertility and Sterility ·doi:10.1016/s0015-0282(98)00086-7

OBJECTIVE: To determine whether hormone replacement therapy (HRT) plus goserelin (Zoladex) is as effective as goserelin alone for the relief of pelvic symptoms of endometriosis and to determine whether it reduces both the loss of bone miner…

article 1996
British journal of obstetrics and gynaecology
article 1993
Fertility and Sterility ·doi:10.1016/s0015-0282(16)55703-3
review 1992
Endocrinology and metabolism clinics of North America ·doi:10.1016/s0889-8529(18)30235-4

Gonadotropin-releasing hormone (GnRH) agonists show promise as new therapeutic agents with considerable potential for clinical applications in endocrinology, gynecology, pediatrics, and oncology. GnRH agonists are derived from GnRH. This ar…

article 1990
Progress in clinical and biological research
review 1988
Clinical obstetrics and gynecology ·doi:10.1097/00003081-198812000-00008
other 1987
Contributions to gynecology and obstetrics
article 1987
Fertility and Sterility

This study was designed to evaluate the effectiveness of three therapeutic modalities in the management of stage I and II endometriosis. Management modalities consisted of no treatment (controls, n = 56); oral medroxyprogesterone acetate (M…

article 1976
Obstetrics and gynecology ·doi:10.1097/00006254-197609000-00021

Efficacy of oral medroxyprogesterone acetate (MPA) was assessed in 35 women with an established diagnosis of endometriosis (33 pelvic and 2 abdominal). MPA was given in a dosage of 30 mg daily for 90 days. Results indicated improvement or r…

article 1975
Fertility and Sterility ·doi:10.1016/s0015-0282(16)41531-1